Pharmacotherapy treatments play a vital role in addressing the strong physical dependence that can develop from electronic cigarette use. This one-hour webinar will discuss developing a treatment regimen that incorporates medications for vaping cessation.
Learning Objectives:
1. Develop an understanding of the role that pharmacotherapy can play in helping patients quit using electronic cigarette devices
2. Describe the process by which a treatment plan is developed that incorporates medication for vaping cessation
3. Describe resources and support systems available for patients for assistance with quitting
Join this webinar hosted by Rethink Tobacco Indiana and presented by Dr. Rhonda Schwindt, Associate Professor, The George Washington University School of Nursing.
Cigarette smoking is the leading known preventable cause of disease and death in the United States. Although significant declines in overall smoking have been achieved, substantial disparities persist in the prevalence of smoking in the transgender and gender diverse community. This program will explore factors associated with the disproportionate impact of tobacco use and the use of culturally-tailored tobacco treatment interventions in this population.
This webinar, presented by Dr. Karen Hudmon, will discuss the role of pharmacy in tobacco cessation, the Indiana Protocol for pharmacists prescribing quit-smoking medications, and how to refer your patients to local pharmacies for help with quitting.
Learning Objectives:
- Develop an understanding of the role that pharmacists can play in helping patients quit using tobacco products.
- Describe the process by which pharmacists implement tobacco treatment services according to the Indiana protocol.
- Describe methods to assist health care organizations and health care providers with referring patients to pharmacies for assistance with quitting.
This one-hour webinar, presented by Dr. Chad Morris, will address the need to establish tobacco treatment as a standard of care, as it interferes with overall recovery for many persons with mental illnesses and addictions. Most individuals who use tobacco want to quit, and tobacco use disorder (TUD) treatment effectively tailored to the behavioral health population can improve treatment outcomes. This presentation will provide health systems with pragmatic, low-burden change strategies and provide clinical guidance for treating TUD. As one means of optimizing care, a co-treatment model will be discussed for TUD and other substance use disorders.
Learning Objectives:
- Delineate the reasons TUD treatment is a key to population health and individual behavioral health recovery goals.
- Describe the compelling factors for co-treatment of TUD, alcohol and other drug use.
- Become familiar with evidence-based strategies for integrating polysubstance use treatment into screening, treatment, and referral.
This 1-hour program will provide insights on billing practices for tobacco treatment services and strategies to advocate for a treatment program in your health system from a nationally-recognized expert.
Following the webinar, participants will be able to:
- Appropriately bill for behavioral health services for provision of tobacco treatment to patients,
- Present justification for a tobacco treatment program in their health system, and
- Understand the differences between revenue and value based programs
This 1-hour program will provide an overview of the five FDA-approved nicotine replacement therapy (NRT) medications and their efficacy in treating tobacco use and dependence. The use of combination NRT will also be discussed, as well as the role of pharmacists in prescribing these medications to help patients quit successfully.
This 30-minute training was developed for community mental health centers (CMHCs) who have Genoa pharmacy locations at their agency sites, however any person may view the training.
By the end of the training, participants will be able to:
• Describe the U.S. tobacco use prevalence among persons with behavioral health conditions,
• Explain the Ask-Advise-Refer (AAR) intervention model and describe the benefits of using AAR, and
• Describe the process of referring patients who are ready to quit to Genoa pharmacists for treatment of tobacco use and dependence.
Most health care providers ask their patients about tobacco use and document the status into their electronic health record, however few bill for tobacco cessation services. While the majority of people who use tobacco want to quit, most will try to quit multiple times before succeeding. Providers in a variety of settings play a critical role in helping patients to quit successfully, especially those who treat patients with behavioral health conditions. An important component of integrating tobacco use treatment into these settings, is ensuring that providers are compensated, which can be confusing and challenging at times.
This 1-hour program will provide an overview of the current tobacco cessation coverage for various payors, review the available billing codes for tobacco cessation treatment, and provide guidance on how behavioral health providers can maximize reimbursement.
People living with mental illness or substance use disorders (i.e. behavioral health conditions) have disproportionately higher rates of tobacco use than the general population. As a result, they also have higher rates of tobacco-related morbidity and mortality. To address these disparities, behavioral health providers must actively provide tobacco treatment and promote cessation among clients.
This 1-hour program will review the 5A’s of tobacco treatment, an evidence-based treatment model for working with tobacco dependent clients. Specific behavioral treatment strategies will be discussed, including ways to motivate clients who may be hesitant to quit and key issues to address when providing counseling.
Quitting smoking can be difficult, but there are proven treatments and strategies to help people quit successfully! Although a majority of cigarette smokers make a quit attempt each year, fewer than one third use cessation medications approved by the U.S. Food and Drug Administration (FDA) or behavioral counseling to support quit attempts.
This 1-hour program will review and compare various tobacco treatment medications for use among persons with behavioral health conditions, introduce the clinical practice guidelines evidence-based recommendations on pharmacologic treatment options, and further detail medication doses, routes, and frequency of administration.
As the tobacco product marketplace evolves, new products are emerging that deliver nicotine to users in different ways. These products include e-cigarettes/vapes such as JUUL or Puff Bars. In the United States, vaping has quickly become a public health epidemic, but what exactly is vaping and what makes it so popular?
During this 1-hour program, we’ll discuss vaping/e-cigarettes, what these products look like, and the ingredients found in e-liquids. We’ll review the prevalence of use among adults and youth and how these products impact Hoosier health. At the end of the webinar, we’ll share strategies and resources available to help people quit.
The impact of tobacco use in Indiana is staggering, costing Hoosiers 11,100 lives each year. About 1 in 5 Hoosier adults (21.1%) were current smokers in 2018. In particular, the smoking rates were HIGHEST among adults with lower education, lower income, uninsured, and those with poor mental health status. Smoking is particularly dangerous for the elderly, who are already at heightened risk for various health conditions such as cardiovascular disease, respiratory conditions, and cancer. Despite the lowered rate of smoking among older adults, the aging of the baby boomers will surely spike the total number of older adults who smoke and are in need of tobacco cessation services in the years to come.
Join us for this 1-hour program as we learn about the specific tobacco cessation services offered through the Medicare program and the Indiana Medicaid program, including an overview of coverage benefits, limitations, HCPCS/CPT codes for billing, and frequently asked questions that often arise when trying to effectively connect patients to these services.
Electronic nicotine delivery systems (ENDS), more commonly referred to as electronic cigarettes (e-cigarettes) or vapes, have become increasingly popular among adults and youth. This webinar course is designed to educate consumers and health professionals on the evolving landscape of ENDS use in the United States, including patterns of use among adults and youth. This 30-minute program will also review the health effects and the marketing tactics of the tobacco industry as they relate to ENDS.
This webinar course is designed to equip peer recovery counselors/specialists and community health workers with the necessary knowledge and skills to assist and support other mental health consumers with quitting tobacco use. This 1-hour program may be used to train fellow peers in a group or individual setting. Tobacco cessation is an important part of recovery.
